CTLA4 and neoplasm: Furthermore, three doses of 8 Gy in combination with anti-CTLA-4 was able to induce a more potent systemic effect and higher frequency of tumor-specific T cells than five doses of 6 Gy plus anti-CTLA-4 (36), suggesting that fractionation influences the induction of anti-tumor immune responses with further immune stimulation (76).